BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Wang Y, Shen X, Chen C, Ni H, Sheng N, Hua M, Wu Y. Down-regulation of lncRNA PCGEM1 inhibits cervical carcinoma by modulating the miR-642a-5p/LGMN axis. Exp Mol Pathol 2020;117:104561. [PMID: 33121976 DOI: 10.1016/j.yexmp.2020.104561] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Luo J, Wang Y, Dong X, Wang W, Mu Y, Sun Y, Zhang F, Miao Y. miR-642a-5p increases glucocorticoid sensitivity by suppressing the TLR4 signalling pathway in THP-1 cells. Biochemistry and Biophysics Reports 2022;32:101356. [DOI: 10.1016/j.bbrep.2022.101356] [Reference Citation Analysis]
2 Ghafouri-fard S, Khoshbakht T, Hussen BM, Baniahmad A, Taheri M, Mokhtari M. A review on the role of PCGEM1 lncRNA in cancer. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154223] [Reference Citation Analysis]
3 Guan B, Chen F, Wu Z, Wang C, Yang J, Wang F. lncRNA PCGEM1 Regulates the Progress of Colorectal Cancer through Targeting miR-129-5p/SOX4. Disease Markers 2022;2022:1-12. [DOI: 10.1155/2022/2876170] [Reference Citation Analysis]
4 Su Y, Gu X, Zheng Q, Zhu L, Lu J, Li L. LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility. Front Oncol 2022;12:847745. [DOI: 10.3389/fonc.2022.847745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Saliani M, Mirzaiebadizi A, Mosaddeghzadeh N, Ahmadian MR. RHO GTPase-Related Long Noncoding RNAs in Human Cancers. Cancers (Basel) 2021;13:5386. [PMID: 34771549 DOI: 10.3390/cancers13215386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kalhori MR, Khodayari H, Khodayari S, Vesovic M, Jackson G, Farzaei MH, Bishayee A. Regulation of Long Non-Coding RNAs by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach. Cancers (Basel) 2021;13:1274. [PMID: 33805687 DOI: 10.3390/cancers13061274] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]